In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cassava Sciences, Inc.

https://www.cassavasciences.com/

Latest From Cassava Sciences, Inc.

Keeping Track: StrataGraft Continues US FDA’s Biologic Center Approvals Streak; Another CRL For Avenue’s Tramadol IV

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Complete Response Letters

China’s First ADC Secures Domestic Approval

RemeGen’s second approval after a green light for its lupus drug signals accelerating approvals for domestically-developed antibodies in China.

China Approvals

China’s First ADC Secures Domestic Approval

RemeGen’s second approval after a green light for its lupus drug signals accelerating approvals for domestically-developed antibodies in China.

China Approvals

Aduhelm Approval Boosts Other Alzheimer’s Drug Developers

Biogen/Eisai’s aducanumab, as the first disease-modifying therapy and setting a precedent for accelerated approval, lifted the entire Alzheimer’s field.

Approvals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Pain Therapeutics, Inc.
UsernamePublicRestriction

Register